Metowin 10 mg Injection 2 ml belongs to a group of medicines called anti-emetics and prokinetic agents used to prevent nausea and vomiting caused by chemotherapy, radiotherapy, migraine, and in post-operative conditions. Additionally, Metowin 10 mg Injection 2 ml is also used to treat delayed gastric emptying. Metowin 10 mg Injection 2 ml may be used to facilitate small bowel intubation and to stimulate gastric emptying and intestinal transit of barium.

Metowin 10 mg Injection 2 ml contains ‘metoclopramide’ that works by increasing the motility of the upper gastrointestinal tract; this allows faster transit of food and treats gastric emptying. It also works on the part of the brain that controls vomiting, thereby helps in preventing nausea and vomiting.

In some cases, Metowin 10 mg Injection 2 ml may cause common side-effects such as drowsiness, fatigue, dizziness, headache, and bowel disturbances. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if the side effects persist or worsen.

Consult your doctor if you are pregnant or breastfeeding. Metowin 10 mg Injection 2 ml may cause drowsiness and dizziness affecting your ability to drive and operate machinery. Metowin 10 mg Injection 2 ml is not recommended for children below one year. Avoid consuming alcohol while on treatment with Metowin 10 mg Injection 2 ml as it could lead to increased drowsiness. Treatment with Metowin 10 mg Injection 2 ml is not recommended for longer than 12 weeks, except in rare cases.

Metowin 10 mg Injection 2 ml belongs to a group of medicines called anti-emetics and prokinetic agents used to prevent nausea and vomiting caused by chemotherapy, radiotherapy, migraine, and in post-operative conditions. Additionally, Metowin 10 mg Injection 2 ml is also used to treat delayed gastric emptying. Metowin 10 mg Injection 2 ml may be used to facilitate small bowel intubation and to facilitate gastric emptying and intestinal transit of barium in patients where delayed emptying interrupts radiological examination of the stomach and/or small intestine. Metowin 10 mg Injection 2 ml contains ‘metoclopramide’ that works by increasing the motility of the upper gastrointestinal tract; this allows faster transit of food and treats gastric emptying. It also works on the part of the brain that controls vomiting, thereby helps in preventing nausea and vomiting.

Do not take Metowin 10 mg Injection 2 ml if you are allergic to any of its components; if you have gastrointestinal bleeding, mechanical obstruction/perforation, pheochromocytoma (tumour in the adrenal glands), or epilepsy. Metowin 10 mg Injection 2 ml may cause neuroleptic malignant syndrome (a nervous disorder with high fever and muscle stiffness), extrapyramidal symptoms (shaking, tremor, stiffness and involuntary movement), Tardive dyskinesia (movement disorder), Parkinson-like symptoms (bradykinesia, tremor, cogwheel rigidity, or mask-like facies), and depression. Inform your doctor if you have heart problems, diabetes, depression, high blood pressure, breast cancer, seizures, Parkinson’s disease, methaemoglobinaemia, or liver or kidney problems. Consult your doctor immediately if you cannot stop or control movements like shaking your arms and legs, blinking and moving your eyes, sticking out the tongue, frowning, lip-smacking, chewing, or puckering up the mouth.